NEW YORK (GenomeWeb) – Bioinformatics startup FactBio has joined the Pistoia Alliance, a non-profit alliance of life science companies, vendors, publishers, and academics that support life sciences research and development.

"The Pistoia Alliance has made excellent progress in supporting life sciences R&D and many of its projects are now having an impact globally," FactBio CEO James Malone said in a statement. "By joining the Pistoia Alliance, we hope to help in tackling some of the challenges faced by life sciences R&D."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.